BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 6, 2026
Home
»
Authors
» Brady Huggett
Brady Huggett
Articles
ARTICLES
Cypress Bioscience Raises $10.3M For Milnacipran Phase III Program
March 28, 2003
By
Brady Huggett
Cypress Bioscience Raises $10.3M For Milnacipran Phase III Program
March 28, 2003
By
Brady Huggett
Alteon Raises $7.7M Privately For ALT-711, Other Products
March 27, 2003
By
Brady Huggett
Merck Accepts Kalypsys Invite, Ends Up Signing Platform Deal
March 27, 2003
By
Brady Huggett
Merck Accepts Kalypsys Invite, Ends Up Signing Platform Deal
March 27, 2003
By
Brady Huggett
Alteon Raises $7.7M Privately For ALT-711, Other Products
March 27, 2003
By
Brady Huggett
Biopure Plans To Raise $13.4M While Awaiting Word From FDA
March 26, 2003
By
Brady Huggett
Biopure Plans To Raise $13.4M While Awaiting Word From FDA
March 26, 2003
By
Brady Huggett
Dermatology Meeting Brings Together Psoriasis Competitors
March 25, 2003
By
Brady Huggett
Dermatology Meeting Brings Together Psoriasis Competitors
March 25, 2003
By
Brady Huggett
View All Articles by Brady Huggett
